Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04964115 · ClinicalTrials.gov registry record
Post Acute Sequelae of COVID-19
A clinical trial of Covid19 and SARS CoV 2 Infection, sponsored by Vanderbilt University Medical Center.
- Active
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT04964115 is a study of Covid19 and SARS CoV 2 Infection that is active but no longer recruiting, run by Vanderbilt University Medical Center. The registered enrollment target is 500 participants, below the 2,697-participant average among 94 other Covid19 trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04964115, a study of Covid19 and SARS CoV 2 Infection, is active but no longer recruiting, sponsored by Vanderbilt University Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
COVID-19, a novel coronavirus, has caused widespread mortality and morbidity since it emerged in 2019. There is ongoing research and growing literature describing severe acute respiratory syndrome (SARS-COV-2). There is a growing population of individuals who have recovered from acute SARS-COV-2 infection. The long-term effects of COVID-19 are unknown. There are growing reports of sequelae after acute SARS-CoV-2 not limited to fatigue, dyspnea, reactive airway disease, organizing pneumonia, pulmonary fibrosis, pulmonary hypertension, pulmonary emboli, and tracheal disease. The incidence and natural history of these findings is unstudied.
Conditions Studied
Interventions
- OTHER Cohort study
Study Locations (1)
Tennessee
- Vanderbilt_University MC - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2021-08-10 |
| Est. Completion | 2027-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04964115
The ClinicalTrials.gov registry entry for NCT04964115 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,697-participant average among 94 other Covid19 trials with a reported enrollment target (81% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Covid19 appearing as the primary indexed condition, and to 1 intervention - of which Cohort study is the first listed.
NCT04964115 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT04964115 about?
NCT04964115 is a clinical study titled "Post Acute Sequelae of COVID-19". COVID-19, a novel coronavirus, has caused widespread mortality and morbidity since it emerged in 2019. There is ongoing research and growing literature describing severe acute respiratory syndrome (SARS-COV-2). There is a growing population of individuals who have recovered from acute SARS-COV-2 inf...
What is the current status of trial NCT04964115?
This trial is currently active not recruiting. The enrollment target is 500 participants. The study started on 2021-08-10. Estimated completion is 2027-05-31.
What conditions does trial NCT04964115 study?
This clinical trial studies the following conditions: Covid19, SARS CoV 2 Infection, Pulmonary Fibrosis, COVID-19 Acute Respiratory Distress Syndrome, Dyspnea Caused by 2019-nCoV.
What interventions are being tested in trial NCT04964115?
The interventions under investigation include: Cohort study (OTHER).
Who is sponsoring clinical trial NCT04964115?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04964115 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Covid19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Imaging Immune Activation in COVID-19
RECRUITING · Phase 2
-
Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
RECRUITING · Phase 2
-
COVID-19 Vaccines International Pregnancy Exposure Registry
RECRUITING
-
COVID-19 Survivorship Registry
RECRUITING
-
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
RECRUITING · Phase 3
-
Conversations You Want About Corona Virus Disease (COVID-19)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.